Helius Medical Technologies (NASDAQ:HSDT) Trading Down 1.7%

Helius Medical Technologies, Inc. (NASDAQ:HSDT) dropped 1.7% on Friday . The company traded as low as $0.80 and last traded at $0.82. Approximately 225,649 shares changed hands during trading, a decline of 35% from the average daily volume of 347,503 shares. The stock had previously closed at $0.83.

Helius Medical Technologies Stock Performance

The company has a market cap of $2.46 million, a price-to-earnings ratio of -0.06 and a beta of 1.61. The firm’s fifty day moving average price is $0.79 and its 200-day moving average price is $2.47.

Helius Medical Technologies (NASDAQ:HSDT) last announced its quarterly earnings results on Monday, August 12th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by ($0.14). Helius Medical Technologies had a negative return on equity of 258.06% and a negative net margin of 1,487.54%. The business had revenue of $0.18 million during the quarter. During the same period in the prior year, the business earned ($3.00) EPS.

Institutional Investors Weigh In On Helius Medical Technologies

An institutional investor recently bought a new position in Helius Medical Technologies stock. Armistice Capital LLC bought a new stake in Helius Medical Technologies, Inc. (NASDAQ:HSDT) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 130,000 shares of the company’s stock, valued at approximately $127,000. Armistice Capital LLC owned approximately 4.39% of Helius Medical Technologies as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 18.63% of the company’s stock.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.